Diabetes Panel

Understanding Your HbA1c & Blood Sugar

HbA1c (glycated haemoglobin) is the gold standard for assessing long-term blood sugar control. Unlike a fasting glucose test that captures a single moment, HbA1c reveals your average blood sugar level over the past 2–3 months. It is the single most important number for diagnosing diabetes, monitoring treatment effectiveness, and predicting your risk of serious complications including heart disease, kidney damage, and nerve damage.

What HbA1c Actually Measures

HbA1c measures the percentage of haemoglobin proteins in your red blood cells that have glucose permanently attached to them. Here is how the process works:

Glucose enters the bloodstream

After eating, carbohydrates are broken down into glucose which enters your blood. Insulin normally moves this glucose into cells for energy. When insulin is insufficient or cells are resistant, glucose accumulates in the bloodstream.

Sugar attaches to haemoglobin

Glucose molecules bind irreversibly to the haemoglobin protein inside red blood cells through a process called glycation. The higher the blood sugar, the more haemoglobin becomes glycated. This bond is permanent for the life of that red blood cell.

Red blood cells live approximately 120 days

Red blood cells are produced in your bone marrow and circulate for about 90–120 days before being recycled by the spleen. At any given time, your blood contains cells of varying ages, which is why A1C reflects a weighted average over 2–3 months, with more recent weeks contributing more to the result.

Higher average sugar = higher A1C percentage

The lab measures what fraction of your haemoglobin is glycated and reports it as a percentage (DCCT) or in mmol/mol (IFCC). A person with consistently normal blood sugar will have about 5% glycated haemoglobin, while someone with poorly controlled diabetes might have 9% or more.

HbA1c Risk Zones

These thresholds are based on American Diabetes Association (ADA), WHO, and RACGP guidelines. Values shown in DCCT % format (IFCC equivalents in the conversion table below).

Normal

< 5.7%

Blood sugar regulation is healthy. Continue routine screening every 1–2 years if you have risk factors.

Prediabetes

5.7% – 6.4%

Blood sugar is above normal but below the diabetes threshold. Lifestyle changes can reverse this.

Diabetes

6.5% – 7.0%

Diagnostic threshold for type 2 diabetes. Treatment targets typically aim for below 7.0% (53 mmol/mol).

Poorly Controlled

> 7.0%

Significantly elevated. Risk of complications rises steeply. Urgent medication review recommended.

DCCT % vs IFCC mmol/mol Conversion

Two measurement systems exist worldwide. Australia, the UK, and most of Europe use IFCC (mmol/mol), while the US and some Asian countries still report DCCT (%). The conversion formula is:

IFCC (mmol/mol) = (DCCT % − 2.15) × 10.929

Example: 7.0% → (7.0 − 2.15) × 10.929 = 53 mmol/mol

DCCT (%)	IFCC (mmol/mol)	Classification
5.0%	31	Normal
5.5%	37	Normal
5.7%	39	Prediabetes threshold
6.0%	42	Prediabetes
6.5%	48	Diabetes threshold
7.0%	53	Diabetes target
7.5%	58	Above target
8.0%	64	Poorly controlled
8.5%	69	Poorly controlled
9.0%	75	Poorly controlled
10.0%	86	Severe
12.0%	108	Severe

Estimated Average Glucose (eAG)

Your A1C can be translated into an estimated average glucose (eAG) value, which represents your typical blood sugar level over the past 2–3 months. This makes it easier to relate your A1C to the daily readings you see on a glucose meter or continuous glucose monitor. The formula used is: eAG (mmol/L) = 1.5944 × A1C − 2.5944.

HbA1c (%)	eAG (mmol/L)	eAG (mg/dL)
5.0%	5.4 mmol/L	97 mg/dL
5.5%	6.2 mmol/L	111 mg/dL
6.0%	7.0 mmol/L	126 mg/dL
6.5%	7.8 mmol/L	140 mg/dL
7.0%	8.6 mmol/L	154 mg/dL
7.5%	9.4 mmol/L	169 mg/dL
8.0%	10.2 mmol/L	183 mg/dL
8.5%	11.0 mmol/L	197 mg/dL
9.0%	11.8 mmol/L	212 mg/dL
10.0%	13.4 mmol/L	240 mg/dL
11.0%	15.0 mmol/L	269 mg/dL
12.0%	16.5 mmol/L	298 mg/dL

Note: eAG is a statistical estimate. Individual glucose variability means your actual daily readings may fluctuate widely even when A1C is on target. Continuous glucose monitoring (CGM) provides a more complete picture of glucose patterns, spikes, and time in range.

Diabetes Complication Risks by Organ

Chronically elevated blood sugar damages blood vessels throughout the body. The landmark DCCT and UKPDS trials showed that every 1% reduction in A1C reduces microvascular complications by approximately 25–35%. These are the six major organ systems at risk.

Eyes

Diabetic Retinopathy

High blood sugar damages the tiny blood vessels in the retina. A1C above 7% doubles the risk of retinopathy progression over 10 years. Annual eye exams are essential.

Risk increases: A1C > 7.0%

Kidneys

Diabetic Nephropathy

Elevated glucose damages the kidney filtration units (glomeruli). Each 1% A1C reduction lowers nephropathy risk by approximately 25%. Monitor eGFR and urine albumin regularly.

Risk increases: A1C > 7.0%

Nerves

Diabetic Neuropathy

Peripheral nerve damage causes tingling, numbness, and pain in the hands and feet. Affects up to 50% of people with diabetes. Tight glucose control slows progression significantly.

Risk increases: A1C > 6.5%

Heart

Cardiovascular Disease

Diabetes doubles the risk of heart attack and stroke. Each 1% increase in A1C raises cardiovascular event risk by 15–20%. Blood pressure and cholesterol management are equally important.

Risk increases: A1C > 6.5%

Feet

Diabetic Foot Ulcers

Neuropathy combined with poor circulation leads to ulcers that heal slowly. Poorly controlled diabetes is the leading cause of non-traumatic lower limb amputation. Daily foot checks are critical.

Risk increases: A1C > 8.0%

Brain

Cognitive Decline

Chronic hyperglycaemia is linked to accelerated cognitive decline and a 60–70% higher risk of dementia. Both type 1 and type 2 diabetes affect memory, processing speed, and executive function.

Risk increases: A1C > 7.0%

What Can Affect Your HbA1c Results

A1C is not a perfect test. Several non-glucose factors can cause your result to be falsely high or low. If your A1C does not match your finger-prick readings or CGM data, one of these conditions may be the reason.

If any of these conditions apply to you, discuss alternative glucose monitoring options with your doctor. Fructosamine testing or continuous glucose monitoring (CGM) may provide more accurate results.

Factor	Effect on A1C	Direction
Iron deficiency anaemia	Falsely elevates A1C because red blood cells live longer when iron is low	Falsely High
Recent blood loss or transfusion	Falsely lowers A1C by replacing old red blood cells with new ones	Falsely Low
Chronic kidney disease	Altered red blood cell lifespan can cause unpredictable A1C readings	Either
Haemoglobin variants (HbS, HbC, HbE)	Can interfere with certain lab methods, giving falsely high or low results	Either
Pregnancy	Haemodilution and increased red cell turnover often lower A1C readings	Falsely Low
Age (over 70)	A1C tends to rise 0.1% per decade due to slower red blood cell turnover	Falsely High
Ethnicity	Some populations (African, Hispanic, Asian) may have naturally higher A1C at the same glucose level	Falsely High
Lab method differences	HPLC, immunoassay, and enzymatic methods can vary by up to 0.3% on the same sample	Either

How Often Should You Test?

The recommended frequency of HbA1c testing depends on your diabetes status and how stable your blood sugar control has been. These recommendations are from the ADA, RACGP, and NICE guidelines.

Group	Recommended Frequency	Notes
Type 1 diabetes	Every 3 months	Essential for insulin dose adjustment. CGM data supplements but does not replace A1C.
Type 2 (well-controlled)	Every 6 months	If stable on oral medication and A1C consistently below 7%, twice yearly is sufficient.
Type 2 (changing treatment)	Every 3 months	When medications change or A1C is above target, more frequent monitoring guides adjustments.
Prediabetes	Annually	Track progress of lifestyle interventions. Revert to 6-monthly if trending upward.
At-risk (no diagnosis)	Every 1–2 years	Family history, obesity, gestational diabetes history, or PCOS. Screening starts at age 35 (ADA).

When to Seek Medical Attention

Contact your doctor promptly if any of the following apply:

A1C above 8.0% (64 mmol/mol) despite current treatment — medication adjustment likely needed
A1C rising steadily over consecutive tests, even if still below target
Symptoms of hyperglycaemia: excessive thirst, frequent urination, blurred vision, unexplained weight loss
Symptoms of hypoglycaemia: shakiness, sweating, confusion, rapid heartbeat (especially if on insulin or sulfonylureas)
Numbness, tingling, or pain in hands or feet (possible neuropathy)
Changes in vision — blurriness, floaters, or dark spots (possible retinopathy)
Swelling in ankles or foamy urine (possible kidney involvement)
Non-healing wounds, especially on the feet

This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment decisions.

Track Your HbA1c Over Time

Upload your blood test results and watch your HbA1c, fasting glucose, and insulin levels trend on interactive charts. See how diet, exercise, and medication changes translate into real improvements — free forever for the first million users.

Get Started Free